Explore More, Faster Than Before
Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, has been awarded Frost & Sullivan’s North American Immunoassay Market New Product Innovation Award for Gyrolab xPlore™.
Frost & Sullivan is a leading, 53 year-old market research and consulting firm that tracks multiple industries including Automotive, Healthcare, Information and Communication Technology, and more.
The Frost & Sullivan Best Practices Awards have identified exemplary achievements within a multitude of industries and functional disciplines for the last 15 years. Frost & Sullivan conducts best practices research to properly identify unrivaled innovation and leadership among companies, products, processes, and executives.
Frost & Sullivan presents the 2015 New Product Innovation Award to Gyros AB for its commitment to dramatically improving the immunoassay workflow. “We greatly appreciate the recognition from Frost & Sullivan, “commented Dan Calvo, CEO at Gyros. “ Market feedback since the launch in February has been outstanding. The Gyros team has done an exceptional job with Gyrolab xPlore, taking feedback from our customers to evolve the Gyrolab platform and deliver an instrument that brings new levels of performance and productivity to a broader group of end users performing immunoassays.”
Frost & Sullivan states that “The newly-launched Gyrolab xPlore™ brings automated nanoliter-scare immunoassay technology to low-to-mid throughput applications and laboratories. This cost-effective follow-on system to Gyros’ flagship Gyrolab™ xP workstation utilizes the same highly advantageous technology of its high-throughput counterpart in a single-CD, smaller footprint instrument. The Gyrolab xPlore™ is the second instrument in the innovative Gyrolab line of immunoassay systems. Gyros’ flagship product, the 21 CFR part-11 complaint Gyrolab™xP workstation, has revolutionized high-throughput immunoassay workflows for many biopharmaceutical laboratories, especially those working with large sample sizes in pre-clinical and clinical settings. This immunoassay platform can analyze up to five proprietary Gyrolab CDs concurrently, generating 560 data points in less than five hours and providing true walk-away automation, maximizing lab productivity.”